Tomassini, V; Sinclair, A; Sawlani, V; Overell, J; Pearson, OR; Hall, J; Guadagno, J
(2020)
Diagnosis and management of multiple sclerosis: MRI in clinical practice.
J Neurol, 267 (10).
pp. 2917-2925.
ISSN 1432-1459
https://doi.org/10.1007/s00415-020-09930-0
SGUL Authors: Sinclair, Audrey Grania
Abstract
BACKGROUND: Recent changes in the understanding and management of multiple sclerosis (MS) have increased the role of MRI in supporting diagnosis and disease monitoring. However, published guidelines on the use of MRI in MS do not translate easily into different clinical settings and considerable variation in practice remains. Here, informed by published guidelines for the use of MRI in MS, we identified a clinically informative MRI protocol applicable in a variety of clinical settings, from district general hospitals to tertiary centres. METHODS: MS specialists geographically representing the UK National Health Service and with expertise in MRI examined existing guidelines on the use of MRI in MS and identification of challenges in their applications in various clinical settings informed the formulation of a feasible MRI protocol. RESULTS: We identified a minimum set of MRI information, based on clinical relevance, as well as on applicability to various clinical settings. This informed the selection of MRI acquisitions for scanning protocols, differentiated on the basis of their purpose and stage of the disease, and indication of timing for scans. Advice on standardisation of MRI requests and reporting, and proposed timing and frequency of MRI scans were generated. CONCLUSIONS: The proposed MRI protocol can adapt to a range of clinical settings, aiding the impetus towards standardisation of practice and offering an example of research-informed service improvement to support optimisation of resources. Other neurological conditions, where a gap still exists between published guidelines and their clinical implementation, may benefit from this same approach.
Item Type: |
Article
|
Additional Information: |
© The Author(s) 2020
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
Keywords: |
Clinical practice, Diagnosis, Disease-modifying treatments, MRI, Monitoring, Multiple sclerosis, 1103 Clinical Sciences, 1109 Neurosciences, Neurology & Neurosurgery |
SGUL Research Institute / Research Centre: |
Academic Structure > Institute of Medical, Biomedical and Allied Health Education (IMBE) Academic Structure > Institute of Medical, Biomedical and Allied Health Education (IMBE) > Centre for Clinical Education (INMECE ) |
Journal or Publication Title: |
J Neurol |
ISSN: |
1432-1459 |
Language: |
eng |
Dates: |
Date | Event |
---|
October 2020 | Published | 29 May 2020 | Published Online | 18 May 2020 | Accepted |
|
Publisher License: |
Creative Commons: Attribution 4.0 |
Projects: |
Project ID | Funder | Funder ID |
---|
Support for meeting | Novartis Pharmaceuticals UK Limited | UNSPECIFIED |
|
PubMed ID: |
32472179 |
|
Go to PubMed abstract |
URI: |
https://openaccess.sgul.ac.uk/id/eprint/112392 |
Publisher's version: |
https://doi.org/10.1007/s00415-020-09930-0 |
Statistics
Item downloaded times since 16 Sep 2020.
Actions (login required)
|
Edit Item |